REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,632,204 | -70.9% | 142,302 | -35.8% | 0.00% | -71.4% |
| Q2 2023 | $5,613,986 | -42.9% | 221,809 | -27.3% | 0.01% | -50.0% |
| Q1 2023 | $9,829,880 | +139.0% | 305,181 | +37.0% | 0.01% | +133.3% |
| Q4 2022 | $4,112,870 | -98.2% | 222,799 | +1232.5% | 0.01% | – |
| Q2 2022 | $231,084,000 | +62.9% | 16,721 | +129.8% | 0.00% | – |
| Q1 2022 | $141,882,000 | -45.5% | 7,276 | -54.4% | 0.00% | – |
| Q4 2021 | $260,549,000 | -45.5% | 15,965 | -7.0% | 0.00% | -100.0% |
| Q3 2021 | $478,300,000 | +85.0% | 17,168 | +96.8% | 0.00% | – |
| Q2 2021 | $258,609,000 | -51.2% | 8,725 | -54.0% | 0.00% | -100.0% |
| Q1 2021 | $530,463,000 | +53.8% | 18,979 | +56.0% | 0.00% | 0.0% |
| Q4 2020 | $344,869,000 | -7.8% | 12,169 | -18.2% | 0.00% | 0.0% |
| Q3 2020 | $374,058,000 | +551.0% | 14,879 | +532.3% | 0.00% | – |
| Q2 2020 | $57,460,000 | -75.3% | 2,353 | -85.0% | 0.00% | – |
| Q1 2020 | $232,286,000 | +172.0% | 15,695 | +198.3% | 0.00% | – |
| Q4 2019 | $85,386,000 | +3.4% | 5,261 | -17.2% | 0.00% | – |
| Q3 2019 | $82,615,000 | +49.2% | 6,355 | +48.9% | 0.00% | – |
| Q2 2019 | $55,356,000 | -55.9% | 4,268 | -46.4% | 0.00% | – |
| Q1 2019 | $125,434,000 | +387.7% | 7,959 | +669.0% | 0.00% | – |
| Q3 2018 | $25,720,000 | -9.5% | 1,035 | 0.0% | 0.00% | – |
| Q2 2018 | $28,411,000 | -83.3% | 1,035 | -81.3% | 0.00% | – |
| Q1 2018 | $170,293,000 | -67.7% | 5,529 | -62.5% | 0.00% | -100.0% |
| Q4 2017 | $527,277,000 | +406.0% | 14,749 | +554.9% | 0.00% | – |
| Q3 2017 | $104,200,000 | +71.5% | 2,252 | -2.1% | 0.00% | – |
| Q2 2017 | $60,746,000 | +2199.2% | 2,301 | +1711.8% | 0.00% | – |
| Q1 2017 | $2,642,000 | -88.9% | 127 | -88.9% | 0.00% | – |
| Q4 2016 | $23,722,000 | -6.0% | 1,146 | -26.4% | 0.00% | – |
| Q3 2016 | $25,239,000 | +89.4% | 1,557 | +58.9% | 0.00% | – |
| Q2 2016 | $13,328,000 | -90.1% | 980 | -75.1% | 0.00% | – |
| Q4 2015 | $134,386,000 | +37.5% | 3,934 | +19.8% | 0.00% | – |
| Q3 2015 | $97,702,000 | +134.6% | 3,283 | +152.2% | 0.00% | – |
| Q2 2015 | $41,638,000 | +924.8% | 1,302 | +564.3% | 0.00% | – |
| Q1 2015 | $4,063,000 | -48.5% | 196 | -52.0% | 0.00% | – |
| Q3 2014 | $7,887,000 | – | 408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |